Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04777214 · ClinicalTrials.gov registry record · NA
TMS in Aphasia Recovery
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT04777214: Completed NA study, sponsored by University of Pennsylvania.
NCT04777214 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04777214, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Stroke often causes substantial problems in speaking or understanding speech. Treatments for these problems are currently very limited. Limited studies to date suggest that repetitive Transcranial Magnetic Stimulation (TMS) to the side of the brain opposite to the side on which the stroke occurred may improve language function. The investigators are testing this hypothesis by giving daily 20 minute sessions of repeated TMS to the right (unaffected) side of the brain; the investigators test language function with a variety of tests both before and after the treatment with TMS and subjects are required to undergo functional MRI scans before and after treatment. TMS is a procedure in which a coil is placed next to the head of the subject and an electrical current passes through the coil causing a magnetic field that, in turn, causes a small electric current in the portion of the brain underneath the coil.
Interventions
- DEVICE Sham TMS
- DEVICE Repetitive Transcranial Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2007-06-26 |
| Est. Completion | 2011-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04777214
The ClinicalTrials.gov registry entry for NCT04777214 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham TMS is the first listed.
NCT04777214 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04777214 about?
NCT04777214 is a clinical study titled "TMS in Aphasia Recovery". Stroke often causes substantial problems in speaking or understanding speech. Treatments for these problems are currently very limited. Limited studies to date suggest that repetitive Transcranial Magnetic Stimulation (TMS) to the side of the brain opposite to the side on which the stroke occurred m...
What is the current status of trial NCT04777214?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2007-06-26. Estimated completion is 2011-08-30.
What interventions are being tested in trial NCT04777214?
The interventions under investigation include: Sham TMS (DEVICE), Repetitive Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT04777214?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.